Trial
NCT02893176
Macitentan in the Treatment of Organ Rejection After Lung Transplantation
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, Los Angeles
Collaborators
—
Condition
Lung Transplant Rejection
Intervention
macitentan
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-11